# A Study of 18F-AV-45 in Alzheimer's Disease (AD) and Healthy Volunteers

> **NCT01565343** · PHASE1 · COMPLETED · sponsor: **Avid Radiopharmaceuticals** · enrollment: 25 (actual)

## Conditions studied

- Alzheimer's Disease

## Interventions

- **DRUG:** florbetapir F 18

## Key facts

- **NCT ID:** NCT01565343
- **Lead sponsor:** Avid Radiopharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-04
- **Primary completion:** 2009-04
- **Final completion:** 2009-04
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2012-05-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01565343

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01565343, "A Study of 18F-AV-45 in Alzheimer's Disease (AD) and Healthy Volunteers". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01565343. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*